What are the major opportunities in the Gastroesophageal Reflux Disease (GERD) market? What are the strategies for the Gastroesophageal Reflux Disease (GERD) market?

For detailed insights on the major opportunities and strategies in the Gastroesophageal Reflux Disease (GERD) market, Read More

How does the Gastroesophageal Reflux Disease (GERD) market relate to the overall economy and other similar markets?

For detailed insights on Gastroesophageal Reflux Disease (GERD)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gastroesophageal Reflux Disease (GERD) market growth? SWOT analysis of the Gastroesophageal Reflux Disease (GERD) market.

For detailed insights on the key dynamics influencing the Gastroesophageal Reflux Disease (GERD) market growth and SWOT analysis of the Gastroesophageal Reflux Disease (GERD) industry, Read More

Gastroesophageal Reflux Disease (GERD) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Gastroesophageal Reflux Disease (GERD) Market Report 2026

Name: Gastroesophageal Reflux Disease (GERD) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist), By Procedure (Invasive, Minimally Invasive), By End-Users (Hospital, Homecare, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastroesophageal Reflux Disease (GERD) Market Overview

• Gastroesophageal Reflux Disease (GERD) market size has reached to $5.33 billion in 2025

• Expected to grow to $6.2 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%

• Growth Driver: Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market

• Market Trend: Innovative Gerd Treatment Technologies Shape The Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastroesophageal Reflux Disease (GERD) Market?

Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back into the esophagus, causing irritation and discomfort. The treatment for the disease includes various medical strategies and interventions employed to manage the symptoms and complications associated with gastroesophageal reflux disease.

The main drug types of gastroesophageal reflux disease are antacids, proton pump inhibitors, h2 receptor blockers, pro kinetic agents, dopamine receptor antagonists, endocinch, stretta, asphyx, transoral incisionless fundoplication (TIF). Antacids are drugs that neutralize stomach acid by raising the pH level in the stomach. The various procedures include invasive and minimally invasive. These are used by various end-users such as hospitals, homecare and specialty clinics.

Gastroesophageal Reflux Disease (GERD) Market Global Report 2026 Market Report bar graph

What Is The Gastroesophageal Reflux Disease (GERD) Market Size and Share 2026?

The gastroesophageal reflux disease (gerd) market size has grown steadily in recent years. It will grow from $5.33 billion in 2025 to $5.46 billion in 2026 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to widespread use of antacids and h2 blockers, rising obesity prevalence, high consumption of processed foods, increased clinical diagnosis rates, availability of generic ppis.

What Is The Gastroesophageal Reflux Disease (GERD) Market Growth Forecast?

The gastroesophageal reflux disease (gerd) market size is expected to see steady growth in the next few years. It will grow to $6.2 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to growth in minimally invasive reflux procedures, demand for long-term symptom management, innovation in endoscopic devices, rising geriatric population, increased patient awareness. Major trends in the forecast period include rising long-term use of proton pump inhibitors, increased adoption of minimally invasive gerd procedures, growing awareness of lifestyle-based disease management, expansion of endoscopic treatment options, higher diagnosis rates through improved screening.

Book your 30 minutes free consultation with our research experts

Global Gastroesophageal Reflux Disease (GERD) Market Segmentation

1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist

2) By Procedure: Invasive, Minimally Invasive

3) By End-Users: Hospital, Homecare, Specialty Clinics

Subsegments:

1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide

2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole

3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine

4) By Prokinetic Agents: Metoclopramide, Domperidone

5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol

What Is The Driver Of The Gastroesophageal Reflux Disease (GERD) Market?

The growing prevalence of esophageal diseases is expected to propel the growth of the gastroesophageal reflux disease (GERD) market going forward. Esophageal diseases are medical conditions that affect the esophagus, a muscular tube connecting the mouth to the stomach. The treatment of esophageal diseases aims to alleviate symptoms, improve quality of life and prevent complications, ultimately promoting better overall health and well-being for gastroesophageal reflux disease-affected individuals. For instance, in January 2023, according to the American Cancer Society, a US-based Professional organization, about 21,560 new esophageal cancer cases are diagnosed yearly in the United States, with 16,120 deaths from esophageal cancer. Therefore, the growing prevalence of esophageal diseases drives the growth of the gastroesophageal reflux disease (GERD) industry.

Key Players In The Global Gastroesophageal Reflux Disease (GERD) Market

Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.

Global Gastroesophageal Reflux Disease (GERD) Market Trends and Insights

Major companies operating in the gastroesophageal reflux disease (GERD) market are focusing on introducing innovative gastroesophageal reflux disease treatment devices to sustain their position in the market. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, launched the new alpHaONE wireless pH-capsule reflux testing diagnostic system designed for diagnosing gastroesophageal reflux disease (GERD). The system provides up to 96 hours of monitoring data and offers a compact design with enlarged buttons and a fail-safe capsule delivery system. The system features a software application with a virtual instruction program and user-customizable symptom buttons for improved user experience.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastroesophageal Reflux Disease (GERD) Market?

In July 2024, Merit Medical Systems, Inc., a US-based provider of healthcare technology and medical devices for radiology, cardiology, oncology, and endoscopy, acquired EndoGastric Solutions, Inc. for an undisclosed amount. With this acquisition, Merit expanded its minimally invasive endoscopy portfolio and strengthened its presence in the gastroesophageal reflux disease (GERD) treatment market. EndoGastric Solutions, Inc., a US-based medical device company, developed and commercialized the EsophyX Z+ system, a transoral incisionless fundoplication device designed for the treatment of chronic GERD.

Regional Outlook

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastroesophageal Reflux Disease (GERD) Market?

The gastroesophageal reflux disease (GERD) market consists of revenues earned by entities by providing pharmaceutical therapies, surgical procedures and diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroesophageal reflux disease (GERD) market also includes sales of gamma-aminobutyric acid type B receptor agonists and alginate antacids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastroesophageal Reflux Disease (GERD) Market Report 2026?

The gastroesophageal reflux disease (gerd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastroesophageal reflux disease (gerd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastroesophageal Reflux Disease (GERD) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.46 billion
Revenue Forecast In 2035	$6.2 billion
Growth Rate	CAGR of 2.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Procedure, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastroesophageal Reflux Disease (GERD) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastroesophageal Reflux Disease (GERD) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastroesophageal Reflux Disease (GERD) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastroesophageal Reflux Disease (GERD) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Long-Term Use Of Proton Pump Inhibitors

4.2.2 Increased Adoption Of Minimally Invasive GERD Procedures

4.2.3 Growing Awareness Of Lifestyle-Based Disease Management

4.2.4 Expansion Of Endoscopic Treatment Options

4.2.5 Higher Diagnosis Rates Through Improved Screening

5. Gastroesophageal Reflux Disease (GERD) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Settings

5.4 Ambulatory Surgical Centers

5.5 Diagnostic Centers

6. Gastroesophageal Reflux Disease (GERD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastroesophageal Reflux Disease (GERD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastroesophageal Reflux Disease (GERD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastroesophageal Reflux Disease (GERD) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastroesophageal Reflux Disease (GERD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastroesophageal Reflux Disease (GERD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastroesophageal Reflux Disease (GERD) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastroesophageal Reflux Disease (GERD) Market Segmentation

9.1. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist

9.2. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Invasive, Minimally Invasive

9.3. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Homecare, Specialty Clinics

9.4. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide

9.5. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole

9.6. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of H2 Receptor Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ranitidine, Famotidine, Nizatidine, Cimetidine

9.7. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Prokinetic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metoclopramide, Domperidone

9.8. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Dopamine Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prochlorperazine, Droperidol

10. Gastroesophageal Reflux Disease (GERD) Market Regional And Country Analysis

10.1. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market

11.1. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastroesophageal Reflux Disease (GERD) Market

12.1. China Gastroesophageal Reflux Disease (GERD) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastroesophageal Reflux Disease (GERD) Market

13.1. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastroesophageal Reflux Disease (GERD) Market

14.1. Japan Gastroesophageal Reflux Disease (GERD) Market Overview

14.2. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastroesophageal Reflux Disease (GERD) Market

15.1. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastroesophageal Reflux Disease (GERD) Market

16.1. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastroesophageal Reflux Disease (GERD) Market

17.1. South Korea Gastroesophageal Reflux Disease (GERD) Market Overview

17.2. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastroesophageal Reflux Disease (GERD) Market

18.1. Taiwan Gastroesophageal Reflux Disease (GERD) Market Overview

18.2. Taiwan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastroesophageal Reflux Disease (GERD) Market

19.1. South East Asia Gastroesophageal Reflux Disease (GERD) Market Overview

19.2. South East Asia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastroesophageal Reflux Disease (GERD) Market

20.1. Western Europe Gastroesophageal Reflux Disease (GERD) Market Overview

20.2. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastroesophageal Reflux Disease (GERD) Market

21.1. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastroesophageal Reflux Disease (GERD) Market

22.1. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastroesophageal Reflux Disease (GERD) Market

23.1. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastroesophageal Reflux Disease (GERD) Market

24.1. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastroesophageal Reflux Disease (GERD) Market

25.1. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market

26.1. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market Overview

26.2. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastroesophageal Reflux Disease (GERD) Market

27.1. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastroesophageal Reflux Disease (GERD) Market

28.1. North America Gastroesophageal Reflux Disease (GERD) Market Overview

28.2. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastroesophageal Reflux Disease (GERD) Market

29.1. USA Gastroesophageal Reflux Disease (GERD) Market Overview

29.2. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastroesophageal Reflux Disease (GERD) Market

30.1. Canada Gastroesophageal Reflux Disease (GERD) Market Overview

30.2. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastroesophageal Reflux Disease (GERD) Market

31.1. South America Gastroesophageal Reflux Disease (GERD) Market Overview

31.2. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastroesophageal Reflux Disease (GERD) Market

32.1. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastroesophageal Reflux Disease (GERD) Market

33.1. Middle East Gastroesophageal Reflux Disease (GERD) Market Overview

33.2. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastroesophageal Reflux Disease (GERD) Market

34.1. Africa Gastroesophageal Reflux Disease (GERD) Market Overview

34.2. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Segmentation By Procedure, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastroesophageal Reflux Disease (GERD) Market Regulatory and Investment Landscape

36. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape And Company Profiles

36.1. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastroesophageal Reflux Disease (GERD) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastroesophageal Reflux Disease (GERD) Market Company Profiles

36.3.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.2. SRS Life Sciences Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Reckitt Benckiser Group Plc Overview, Products and Services, Strategy and Financial Analysis

37. Gastroesophageal Reflux Disease (GERD) Market Other Major And Innovative Companies

Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited

38. Global Gastroesophageal Reflux Disease (GERD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease (GERD) Market

40. Gastroesophageal Reflux Disease (GERD) Market High Potential Countries, Segments and Strategies

40.1 Gastroesophageal Reflux Disease (GERD) Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastroesophageal Reflux Disease (GERD) Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastroesophageal Reflux Disease (GERD) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gastroesophageal Reflux Disease (GERD) Market, Overview Of Key Products - Product Examples

Table 2: Global Gastroesophageal Reflux Disease (GERD) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gastroesophageal Reflux Disease (GERD) Market, Supply Chain Analysis

Table 4: Global Gastroesophageal Reflux Disease (GERD) Market, Major Raw Material Providers

Table 5: Global Gastroesophageal Reflux Disease (GERD) Market, Major Resource Providers

Table 6: Global Gastroesophageal Reflux Disease (GERD) Market, Major Manufacturers (Suppliers)

Table 7: Global Gastroesophageal Reflux Disease (GERD) Market, Major Distributors And Channel Partners

Table 8: Global Gastroesophageal Reflux Disease (GERD) Market, Key Technologies & Future Trends

Table 9: Global Gastroesophageal Reflux Disease (GERD) Market, Major Trends

Table 10: Global Gastroesophageal Reflux Disease (GERD) Market, Major End Users

Table 11: Global Gastroesophageal Reflux Disease (GERD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gastroesophageal Reflux Disease (GERD) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gastroesophageal Reflux Disease (GERD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gastroesophageal Reflux Disease (GERD) Market - TAM, US$ Billion, 2025

Table 15: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of H2 Receptor Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Prokinetic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Dopamine Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Gastroesophageal Reflux Disease (GERD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Gastroesophageal Reflux Disease (GERD) Market - Company Scoring Matrix

Table 99: GlaxoSmithKline PLC Financial Performance

Table 100: SRS Life Sciences Financial Performance

Table 101: Takeda Pharmaceutical Company Limited Financial Performance

Table 102: AstraZeneca Plc Financial Performance

Table 103: Reckitt Benckiser Group Plc Financial Performance

Table 104: Global Gastroesophageal Reflux Disease (GERD) Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Gastroesophageal Reflux Disease (GERD) Market, Competitive Dashboard

Table 106: Global Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 108: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By Procedure, 2025 – 2030

Table 109: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

Figure 1: Global Gastroesophageal Reflux Disease (GERD) Market, Overview Of Key Products - Product Examples

Figure 2: Global Gastroesophageal Reflux Disease (GERD) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gastroesophageal Reflux Disease (GERD) Market, Supply Chain Analysis

Figure 4: Global Gastroesophageal Reflux Disease (GERD) Market, Major Raw Material Providers

Figure 5: Global Gastroesophageal Reflux Disease (GERD) Market, Major Resource Providers

Figure 6: Global Gastroesophageal Reflux Disease (GERD) Market, Major Manufacturers (Suppliers)

Figure 7: Global Gastroesophageal Reflux Disease (GERD) Market, Major Distributors And Channel Partners

Figure 8: Global Gastroesophageal Reflux Disease (GERD) Market, Key Technologies & Future Trends

Figure 9: Global Gastroesophageal Reflux Disease (GERD) Market, Major Trends

Figure 10: Global Gastroesophageal Reflux Disease (GERD) Market, Major End Users

Figure 11: Global Gastroesophageal Reflux Disease (GERD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gastroesophageal Reflux Disease (GERD) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gastroesophageal Reflux Disease (GERD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gastroesophageal Reflux Disease (GERD) Market - TAM, US$ Billion, 2025

Figure 15: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of H2 Receptor Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Prokinetic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Dopamine Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Gastroesophageal Reflux Disease (GERD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Gastroesophageal Reflux Disease (GERD) Market - Company Scoring Matrix

Figure 99: GlaxoSmithKline PLC Financial Performance

Figure 100: SRS Life Sciences Financial Performance

Figure 101: Takeda Pharmaceutical Company Limited Financial Performance

Figure 102: AstraZeneca Plc Financial Performance

Figure 103: Reckitt Benckiser Group Plc Financial Performance

Figure 104: Global Gastroesophageal Reflux Disease (GERD) Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Gastroesophageal Reflux Disease (GERD) Market, Competitive Dashboard

Figure 106: Global Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 108: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By Procedure, 2025 – 2030

Figure 109: Global, Gastroesophageal Reflux Disease (GERD) Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Next-Generation Data Storage Global Market Report 2025 – By ???? (Direct Attached Storage (DAS), Network Attached Storage (NAS), Storage Area Network (SAN), Other Types), By Technology (Magnetic Storage, Hybrid Flash Arr...

Animal Disinfectants Market Report 2026 - Global Outlook – By Type (Iodine, Lactic Acid, Hydrogen Peroxide, Phenolic Acid, Quaternary Compounds, Chlorine, Other Types), By Chemical Type (Quaternary Ammonium Chloride Salt...

Mortar Mixing Equipment Market Report 2026 - Global Outlook – By Type (Twin Shaft Mixer, Diesel Mixer, Drum Rotating Mixer, Tilting Mixer, Non-Tilting Mixer), By Application (Tile Adhesive, Water-Proofing Slurry, Concret...

Military Infrastructure Market Report 2026 - Global Outlook – By Type (Harbor, Proving Ground, Range, Training Course), By Size (Small, Medium, Large), By Application (Army, Navy, Air Force) – Market Size, Trends, Strate...

Frequently Asked Questions

What is the projected market size of the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market by 2030?

The Gastroesophageal Reflux Disease (GERD) Market Report 2026 market was valued at $5.33 billion in 2025, increased to $5.46 billion in 2026, and is projected to reach $6.2 billion by 2030. request a sample here

What is the expected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market during the forecast period 2025–2030 is 3.3%. request a sample here

What are the key factors driving the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market?

Major growth driver of the market includes: Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market in the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market report?

The gastroesophageal reflux disease (gerd) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol request a sample here

What is the anticipated growth trend for the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market?

Major trend in this market includes: Innovative Gerd Treatment Technologies Shape The Market For further insights on this market, request a sample here.

Who are the key players in the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market?

Major companies operating in the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market are Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc. request a sample here.

Which region has the most growth potential in the Gastroesophageal Reflux Disease (GERD) Market Report 2026 market?

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease (gerd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.